Search research articles
Contact Us
Filters
Showing results (191-200 of 350) with videos related to
Page
of 35
Sort By:
Frontiers in Medicine
|
November 5, 2019
Inflammatory Bowel Disease (IBD)-A Textbook Case for Multi-Centric Banking of Human Biological Materials
Isabelle Cleynen, Loes Linsen, Sare Verstockt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 9, 2025
Infliximab and Ustekinumab Clearance Better Predict Endoscopic Outcomes Than Trough Concentrations in Crohn's Disease
Zhigang Wang, Yannick Hoffert, Wei Zhang, et al.
Gut Microbes
|
June 27, 2022
Microbiota, not host origin drives <i>ex vivo</i> intestinal epithelial responses
Kaline Arnauts, Padhmanand Sudhakar, Sare Verstockt, et al.
Journal of Crohn'S & Colitis
|
April 18, 2023
Results of the Eighth Scientific Workshop of ECCO: Pathophysiology and Risk Factors of Postoperative Crohn's Disease Recurrence after an Ileocolonic Resection
Pauline Rivière, Gabriele Bislenghi, Nassim Hammoudi, et al.
Inflammatory Bowel Diseases
|
August 11, 2011
Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy
Fabian Schnitzler, Herma Fidder, Marc Ferrante, et al.
Inflammatory Bowel Diseases
|
May 30, 2014
Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitis
Magali de Bruyn, Ingrid Arijs, Willem-Jan Wollants, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 6, 2014
Long-term outcome of patients with Crohn's disease who discontinued infliximab therapy upon clinical remission
Konstantinos Papamichael, Niels Vande Casteele, Ann Gils, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 29, 2018
Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases
Erwin Dreesen, Bram Verstockt, Sumin Bian, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 16, 2024
Efficacy and Safety of Ustekinumab for Chronic Pouchitis: A Prospective Open-label Multicenter Study
An Outtier, Edouard Louis, Olivier Dewit, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 19, 2015
Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis
Konstantinos Papamichael, Thomas Van Stappen, Niels Vande Casteele, et al.
Page
of 35
Search research articles
Search
Showing results (191-200 of 350) with videos related to
Sort By:
Page
of 35
Frontiers in Medicine
|
November 5, 2019
Inflammatory Bowel Disease (IBD)-A Textbook Case for Multi-Centric Banking of Human Biological Materials
Isabelle Cleynen, Loes Linsen, Sare Verstockt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 9, 2025
Infliximab and Ustekinumab Clearance Better Predict Endoscopic Outcomes Than Trough Concentrations in Crohn's Disease
Zhigang Wang, Yannick Hoffert, Wei Zhang, et al.
Gut Microbes
|
June 27, 2022
Microbiota, not host origin drives <i>ex vivo</i> intestinal epithelial responses
Kaline Arnauts, Padhmanand Sudhakar, Sare Verstockt, et al.
Journal of Crohn'S & Colitis
|
April 18, 2023
Results of the Eighth Scientific Workshop of ECCO: Pathophysiology and Risk Factors of Postoperative Crohn's Disease Recurrence after an Ileocolonic Resection
Pauline Rivière, Gabriele Bislenghi, Nassim Hammoudi, et al.
Inflammatory Bowel Diseases
|
August 11, 2011
Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy
Fabian Schnitzler, Herma Fidder, Marc Ferrante, et al.
Inflammatory Bowel Diseases
|
May 30, 2014
Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitis
Magali de Bruyn, Ingrid Arijs, Willem-Jan Wollants, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 6, 2014
Long-term outcome of patients with Crohn's disease who discontinued infliximab therapy upon clinical remission
Konstantinos Papamichael, Niels Vande Casteele, Ann Gils, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 29, 2018
Evidence to Support Monitoring of Vedolizumab Trough Concentrations in Patients With Inflammatory Bowel Diseases
Erwin Dreesen, Bram Verstockt, Sumin Bian, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 16, 2024
Efficacy and Safety of Ustekinumab for Chronic Pouchitis: A Prospective Open-label Multicenter Study
An Outtier, Edouard Louis, Olivier Dewit, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 19, 2015
Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis
Konstantinos Papamichael, Thomas Van Stappen, Niels Vande Casteele, et al.
Page
of 35